Testosterone decreases lipoprotein(a) in men

American Journal of Cardiology

Volumn 77, Issue 14, 1996, Pages 1244-1247

  Zmuda, Joseph M ^b   Thompson, Paul D ^a   Dickenson, Roberta ^b   Bausserman, Linda L ^b  

^a UNIVERSITY OF PITTSBURGH MEDICAL CENTER   (United States)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

LIPOPROTEIN A; TESTOLACTONE; TESTOSTERONE ENANTATE;

ADULT; ARTICLE; ATHEROSCLEROSIS; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CROSSOVER PROCEDURE; HORMONAL REGULATION; HORMONE DETERMINATION; HUMAN; HUMAN CELL; HUMAN EXPERIMENT; HUMAN TISSUE; INTRAMUSCULAR DRUG ADMINISTRATION; LIPOPROTEIN BLOOD LEVEL; MALE; NORMAL HUMAN; ORAL DRUG ADMINISTRATION; PATHOPHYSIOLOGY; PRIORITY JOURNAL; RISK ASSESSMENT; RISK FACTOR; TESTOSTERONE BLOOD LEVEL;

EID: 0029884931     PISSN: 00029149     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0002-9149(96)00174-9     Document Type: Article

References (20)

1. Scanu AM. Lipoprotein(a): a genetic risk factor for premature coronary heart disease. JAMA 1992;267:3326-3329.
2. Carlson LA, Hamsten A, Asplund A. Pronounced lowering of serum levels of lipoprotein Lp(a) in hyperlipidaemic subjects treated with nicotinic acid. J Intern Med 1989;226:271-276.
3. Sacks FM, McPherson R, Walsh BW. Effect of postmenopausal estrogen replacement on plasma Lp(a) lipoprotein concentrations. Arch Intern Med 1994;154:1106-1110.
4. Albers JJ, Taggart HM, Applebaum-Bowden D, Hafner S, Chestnut CH, Hazzard WR. Reduction of lecithin-cholesterol acyltransferase, apolipoprotein D and the Lp(a) lipoprotein with the anabolic steroid stanozolol. Biochim Biophys Acta 1984;795:293-296.
5. MacDonald PC, Madden JD, Brenner PF, Wilson JD, Siiteri PK. Origin of estrogen in normal men and in women with testicular feminization. J Clin Endocrinol Metab 1979;49:905-916.
6. Zmuda JM, Fahrenbach MC, Younkin BT, Bausserman LL, Terry RB, Catlin DH, Thompson PD, The effect of testosterone aromatization on high-density lipoprotein cholesterol level and postheparin lipolytic activity. Metabolism. 1993;42:446-450.
7. Handelsman DJ, Parley TMM, Waites GMH. Contraceptive efficacy of testosterone-induced azoospermia in normal men. Lancet. 1990;336:955-959.
8. Santen RJ. The testis. In: Felig P, Baxter JD, Broadus AE, Frohman LA, eds. Endocrinology and Metabolism. 2nd ed. New York: McGraw-Hill Book Co; 1987:821-905.
9. Glantz SA. Primer of Biostatistics. 3rd ed. New York: McGraw-Hill, Inc; 1992.
10. Kostner GM, Gavish D, Leopold B, Bolzano K, Weintraub MS, Breslow JL. HMG CoA reductase inhibitors lower LDL cholesterol without reducing Lp(a) levels. Circulation. 1989;80:1313-1319.
11. Brewer HH. Effectiveness of diet and drugs in the treatment of patients with elevated Lp(a) levels. In: Scanu AM, ed. Lipoprotein(a). San Diego, Calif: Academic Press, Inc; 1990:211-221.
12. Dufaux B, Order U, Muller R, Hollmann W. Delayed effects of prolonged exercise on serum lipoproteins. Metabolism 1986;35:105-109.
13. Rader DJ, Cain W, Zech LA, Usher D, Brewer HB. Variation in lipoprotein(a) concentrations among individuals with the same apolipoprotein (a) isoform is determined by the rate of Lipoprotein (a) production. J Clin Invest 1993;91:443-447.
14. Frazer KA, Narla G, Zhang JL, Rubin EM. The apolipoprotein (a) gene is regulated by sex hormones and acute-phase inducers in YAC transgenic mice. Nature Genetics 1995;9:424-431.
15. Thompson PD, Cullinane EM, Sady SP, Chenevert C, Saritelli AL, Sady MA, Herbert PN. Contrasting effects of testosterone and stanozolol on serum lipoprotein levels. JAMA 1989;261:1165-1168.
16. Gilligan DM, Quyyumi AA, Cannon RO III. Effects of physiological levels of estrogen on coronary vasomotor function in postmenopausal women. Circulation 1994;89:2545-2551.
17. Jaffe MD. Effect of testosterone cypionate on postexercise ST segment depression. Br Heart J 1977;39:1217-1222.
18. Yue P, Chatterjee K, Beale C, Poole-Wilson PA, Collins P. Testosterone relaxes rabbit coronary arteries and aorta. Circulation 1995;91:1154-1160.
19. Bhasin S. Androgen treatment of hypogonadal men. J Clin Endocrinol Metab 1992;74:1221-1225.
20. Bardin CW, Swerdfoff RS, Santen RJ. Androgens: risks and benefits. J Clin Endocrinol Metab 1991;73:4-7.